InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-12 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
| 2025-04-07 | Jefferson Shreve(R-IN06) | house | Purchase | $15,001 - $50,000 |
| 2025-02-24 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
| 2025-02-12 | Julie Johnson(D-TX32) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $5.14B-4.4% | $5.38B-44.1% | $9.62B+31.4% | $7.32B | — |
| Cost of goods sold | $4.47B-15.8% | $5.31B-37.0% | $8.43B+98.6% | $4.25B+82.2% | $2.33B |
| Gross profit | $668.7M+969.3% | $62.5M-94.7% | $1.19B-61.4% | $3.07B+208.1% | $998.0M |
| Selling, general and administrative expenses | $550.0M-11.0% | $618.0M-32.1% | $910.0M+73.6% | $524.1M+18.7% | $441.5M |
| Goodwill impairment | $181.1M | $0 | $0 | — | — |
| Long-lived asset impairment charges | $245.6M | $0 | $0 | — | — |
| Restructuring charges and asset write-offs | $7.7M-99.3% | $1.13B+11851.5% | $9.5M | — | — |
| Research and development expenses | $51.4M-40.7% | $86.7M+1.2% | $85.7M+19.1% | $72.0M+33.2% | $54.0M |
| Gain on change in interest in properties/sale of business, net | $0 | $0+100.0% | -$71.2M | — | — |
| Operating (loss) profit | -$367.1M+79.3% | -$1.78B-805.3% | $251.9M-89.8% | $2.47B | — |
| Interest and financing expenses | -$207.7M-25.4% | -$165.6M-42.7% | -$116.1M+5.6% | -$123.0M-100.0% | -$61.5M |
| Other income, net | $22.7M-87.3% | $178.3M+60.8% | $110.9M+28.5% | $86.4M | — |
| (Loss) income before income taxes and equity in net income of unconsolidated investments | -$552.1M+68.7% | -$1.76B-814.9% | $246.7M-89.9% | $2.43B | — |
| Income tax expense | $156.9M+80.1% | $87.1M-79.8% | $430.3M+10.2% | $390.6M+1226.5% | $29.4M |
| Loss before equity in net income of unconsolidated investments | -$709.0M+61.7% | -$1.85B-908.5% | -$183.5M | — | — |
| Equity in net income of unconsolidated investments (net of tax) | $243.7M-65.9% | $715.4M-61.4% | $1.85B+140.1% | $772.3M+706.4% | $95.8M |
| Net (loss) income | -$465.2M+59.0% | -$1.14B-168.0% | $1.67B-40.7% | $2.82B | — |
| Net income attributable to noncontrolling interests | -$45.4M-3.3% | -$44.0M+54.7% | -$97.1M+22.5% | -$125.3M-64.3% | -$76.3M |
| Net (loss) income attributable to Albemarle Corporation | -$510.6M+56.7% | -$1.18B-175.0% | $1.57B-41.5% | $2.69B | — |
| Mandatory convertible preferred stock dividends | -$166.8M-22.0% | -$136.6M | $0 | $0 | — |
| Net (loss) income attributable to Albemarle Corporation common shareholders, basic | -$677.4M+48.5% | -$1.32B-183.6% | $1.57B-41.5% | $2.69B | — |
| Net (loss) income attributable to Albemarle Corporation common shareholders, diluted | -$677.4M+48.5% | -$1.32B-183.6% | $1.57B-41.5% | $2.69B | — |
| Basic earnings (loss) per share attributable to common shareholders (in dollars per share) | -$6K+48.6% | -$11K-183.5% | $13K-41.6% | $23K | — |
| Diluted earnings (loss) per share attributable to common shareholders (in dollars per share) | -$6K+48.6% | -$11K-183.8% | $13K-41.5% | $23K | — |
| Weighted-average common shares outstanding—basic (in shares) | $117.7M+0.1% | $117.5M+0.2% | $117.3M+0.2% | $117.1M+1.1% | $115.8M |
| Weighted-average common shares outstanding—diluted (in shares) | $117.7M+0.1% | $117.5M-0.2% | $117.8M-0.0% | $117.8M+1.1% | $116.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
Can Capacity Expansion Position ALB for the Next Growth Phase?
LYB to Report Q1 Earnings: What's in the Cards for the Stock?
A Look At Albemarle’s Valuation After Its Strong 1 Year Shareholder Return